Quanterix Corporation (QTRX)
NASDAQ: QTRX · Real-Time Price · USD
5.26
-0.02 (-0.38%)
At close: Sep 17, 2025, 4:00 PM EDT
5.26
0.00 (0.00%)
After-hours: Sep 17, 2025, 4:10 PM EDT
Quanterix Market Cap
Quanterix has a market cap or net worth of $244.41 million as of September 17, 2025. Its market cap has decreased by -51.92% in one year.
Market Cap
244.41M
Enterprise Value
22.49M
1-Year Change
-51.92%
Ranking
Category
Stock Price
$5.26
Market Cap Chart
Since December 7, 2017, Quanterix's market cap has decreased from $370.01M to $244.41M, a decrease of -33.94%. That is a compound annual growth rate of -5.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 245.34M | -40.09% |
| Dec 31, 2024 | 409.51M | -60.41% |
| Dec 29, 2023 | 1.03B | 101.53% |
| Dec 30, 2022 | 513.21M | -66.97% |
| Dec 31, 2021 | 1.55B | 5.52% |
| Dec 31, 2020 | 1.47B | 122.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |